# Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

> **NCT06200168** · PHASE3 · RECRUITING · sponsor: **Jiuda Zhao** · enrollment: 370 (estimated)

## Conditions studied

- Electroacupuncture
- Olanzapine-contained Four-drug Antiemetic
- Nausea and Vomiting

## Interventions

- **DEVICE:** Electroacupuncture
- **DRUG:** Standard antiemetic treatment
- **DEVICE:** Sham electroacupuncture
- **DRUG:** Standard antiemetic treatment

## Key facts

- **NCT ID:** NCT06200168
- **Lead sponsor:** Jiuda Zhao
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-16
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 370 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06200168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06200168, "Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06200168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*